| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/25/1996 | CA2194447A1 Recombinant kat enzyme and process for its preparation |
| 01/25/1996 | CA2193992A1 New pharmaceutical preparation for pain management |
| 01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | CA2188680A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/24/1996 | EP0693489A1 Heterocyclic tachykinin receptor antagonists |
| 01/24/1996 | EP0693481A1 Prodrugs of 5,5-diphenylhydantoin as antiepileptic and antiarrhythmic agents |
| 01/24/1996 | EP0693475A1 1-Phenyl-3-dimethylamino-propane derivatives having pharmacological activity |
| 01/24/1996 | EP0693282A2 Duloxetine enteric pellets |
| 01/24/1996 | EP0693281A2 Fluoxetine Pharmaceutical formulations |
| 01/24/1996 | EP0693070A1 PYRIDO 2,3-b] 1,4]BENZODIAZEPINONES AS M 2? RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| 01/24/1996 | EP0693069A1 Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancer useful in the treatment of cognitive disorders |
| 01/24/1996 | EP0693068A1 Phenylpyrrole derivatives and their use as antipsychotic agents |
| 01/24/1996 | EP0693062A1 Heterocyclic derivatives in the treatment of ischaemia and related diseases |
| 01/24/1996 | EP0693059A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 01/24/1996 | EP0693053A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/24/1996 | EP0692962A1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses |
| 01/24/1996 | EP0576611A4 Radiopharmaceutical agents for the detection of alzheimer's disease |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/24/1996 | CN1115575A Novel phenylethyl and phenylpropylamines |
| 01/24/1996 | CN1030766C Method for preparing of serotonin 5HTIA agonists |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486541 For treating parkinson*s disease, memory disorders, alzheimer*s disease, depression or hyperactive syndrome |
| 01/23/1996 | US5486534 3,4-substituted pyrazoles for the treatment of inflammation |
| 01/23/1996 | US5486532 Adrenergic agonist |
| 01/23/1996 | US5486528 Antiulcer agents, anxiolytic agents |
| 01/23/1996 | US5486526 Histamine H3 -receptor antagonists and therapeutic uses thereof |
| 01/23/1996 | US5486518 4-indolylpiperazinyl derivatives |
| 01/23/1996 | US5486514 Carbamate derivatives |
| 01/23/1996 | US5486513 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors or enkephalinase and ace |
| 01/23/1996 | US5486512 Learning enhancement |
| 01/23/1996 | CA2154116A1 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists |
| 01/23/1996 | CA1337973C Extracts of ginkgo biloba and their methods of preparation |
| 01/22/1996 | EP0700378A4 Compounds which release nitric oxide |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001115A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 01/18/1996 | WO1996001113A1 Method and medicine for alleviating jet lag |
| 01/18/1996 | DE4425146A1 Verwendung heterocyclischer Verbindungen Use of heterocyclic compounds |
| 01/18/1996 | DE4425144A1 Triazolverbindungen und deren Verwendung Triazole compounds and the use thereof |
| 01/18/1996 | DE4425143A1 Substituierte Pyrimidinverbindungen und deren Verwendung Substituted pyrimidine compounds and their use |
| 01/18/1996 | DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff |
| 01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
| 01/18/1996 | DE4424678A1 Dioxo-thiopyrano-pyridin-carbonsäure-derivate Dioxo-thiopyrano-pyridine-carboxylic acid derivatives |
| 01/18/1996 | CA2193473A1 Method and medicine for alleviating jet lag |
| 01/17/1996 | EP0692484A1 Benzothiadiazine derivative process for its preparation and pharmaceutical compositions containing it |
| 01/17/1996 | EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use |
| 01/17/1996 | EP0691985A1 Phosphonomethyldipeptides |
| 01/17/1996 | EP0691973A1 THIENO-INDOLE DERIVATIVES AS 5HT2c AND 5HT2b ANTAGONISTS |
| 01/17/1996 | EP0691971A1 7-azabicyclo- 2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents |
| 01/17/1996 | EP0691970A1 Imidazoloquinoxalinone derivatives as eaa antagonists |
| 01/17/1996 | EP0691969A1 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE |
| 01/17/1996 | EP0691966A1 Quinolines as type iv phosphodiesterase inhibitors |
| 01/17/1996 | EP0691960A1 Antipsychotic benzimidazole derivatives |
| 01/17/1996 | EP0691956A1 3-phenyl-1,2,5,6-tetrahydropyridine derivatives as sedatives |
| 01/17/1996 | EP0691846A1 Imidazolo-quinoxalinones for treating diseases of the central nervous system |
| 01/17/1996 | EP0691844A1 Method for treating amyloidosis |
| 01/17/1996 | EP0691842A1 Lidocaine aerosol anaesthetic |
| 01/17/1996 | EP0635014B1 Indole derivatives as 5-ht1-like agonists |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | EP0522128B1 Water-dispersible tablets |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/16/1996 | US5484944 Anxiety, sleep, memory |
| 01/16/1996 | US5484942 Chemical intermediates for compounds that are antagonist for substance p such as analgesics, antiinflammatory agents, cns agents, antispasmodics or immunological effects |
| 01/16/1996 | US5484931 2-methyl-3-trifluoromethylaniline, methylation of 2-chloro-5-trifluoromethylpivalanilide |
| 01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
| 01/16/1996 | US5484833 Derivatives of non-steroidal anti-inflammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them |
| 01/16/1996 | US5484804 Perhydroisoindole derivatives as antagonists of substance P |
| 01/16/1996 | US5484793 Nervous system disorders; cognition activators; alzheimer*s disease |
| 01/16/1996 | US5484780 Angiotensin II antagonists |
| 01/16/1996 | US5484775 Semisynthetic ganglioside analogues |
| 01/16/1996 | US5484774 2, N6 -disubstituted adenosines, tri-O-ester derivatives and their pharmaceutical compositions to treat ischemias |
| 01/16/1996 | US5484595 Process for preparation of dibenzocyclooctadiene type lignan |
| 01/14/1996 | CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application |
| 01/11/1996 | WO1996000790A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000720A1 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 01/11/1996 | WO1996000581A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | WO1996000537A1 Microcapsules for administration of neuroactive agents |
| 01/11/1996 | CA2193828A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | CA2190883A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/10/1996 | EP0691342A1 Benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/10/1996 | EP0691339A1 Amine derivatives of 1,3-dihydro-2H-pyrrolo(2,3-b)pyridin-2-ones and oxazolo(4,5-b)pyridin-2(3H)-ones, their process of preparation and pharmaceutical compositions containing them |
| 01/10/1996 | EP0691128A1 Methods of administering CRF antagonists |
| 01/10/1996 | EP0690863A1 Tetracyclic compounds as dopamine agonists |
| 01/10/1996 | EP0690850A1 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists |
| 01/10/1996 | EP0690845A1 Piperazine derivatives as 5-ht1a ligands |
| 01/10/1996 | EP0690843A1 Indoletetralins having dopaminergic activity |
| 01/10/1996 | EP0690842A1 4-arylisoindole analgesics |
| 01/10/1996 | EP0690719A1 Dry mix formulation for bisphosphonic acids |
| 01/10/1996 | EP0558570B1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/10/1996 | EP0556329B1 Substituted piperazines as central nervous system agents |
| 01/10/1996 | EP0495879B1 Compositions and methods for weight reduction |
| 01/10/1996 | EP0487611B1 Herpes simplex virus type 1 mutant |
| 01/10/1996 | CN1114651A 3-indolylpiperidine |
| 01/09/1996 | US5482943 (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl-alkyl-(2,9-disubstituted-4H-pyrido[1,2-a]pyrimidin-4-one) derivatives |
| 01/09/1996 | US5482938 Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| 01/09/1996 | US5482712 Galenic composition |
| 01/09/1996 | CA2153432A1 Substituted 1-(7-chloroquinolin-4-yl) pyrazole-3-carboxamide n-oxide derivatives, method of preparing them and the pharmaceutical compositions in which they are present |
| 01/09/1996 | CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use |
| 01/08/1996 | CA2153294A1 1,3-dihydro-2h-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2(3h)-one amino derivatives; process for preparing the same and pharmaceutical compositions containing them |